Attachment B - Salient Characteristics - MSI Testing Cartridges.docx

This document is an Attachment B detailing Salient Characteristics for MSI (Microsatellite Instability) Testing Reagent Cartridges for the Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System. The solicitation (RFQ 36C26225Q1039) seeks a Firm-Fixed Price contract for automated MSI testing cartridges with specific technical requirements, including: a fully automated assay with no sample extraction, a testing result in approximately 150 minutes, capability to test on 1 FFPE tissue section, and qualitative detection of mutations in 7 specific loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2).

Key procurement details include a one-year performance period, delivery to the VA Greater Los Angeles Healthcare System, and a requirement for items to be shipped within 72 hours of order placement. The solicitation is set for full and open competition under NAICS code 325413, with quotes due by July 3, 2025. The evaluation will be based on the lowest-priced quotation meeting all salient characteristics, with the government reserving the right to award a single contract to a responsive and responsible offeror. The specific brand named in the solicitation is the Biocartis Idylla MSI Assay, with an estimated annual quantity of 53 kits.